PURPOSE: Some patients continue to have bothersome lower urinary tract symptoms despite treatment. We examined characteristics associated with bother from lower urinary tract symptoms in a prospective cohort. MATERIALS AND METHODS: In this 1-year prospective, observational cohort study we obtained data on patients with lower urinary tract symptoms who were seeking care at a total of 6 tertiary care centers in the United States. Participants answered the AUA-SI (American Urological Association Symptom Index) global urinary bother question at study entry and 12 months later. Multilevel logistic and linear regression was used to identify factors associated with worsening bother and bother at 12 months, respectively. RESULTS: Of the 756 participants 121 (16%) had worsened lower urinary tract symptom bother during the study period. When adjusted for other variables, worsened lower urinary tract symptom bother was more likely among men who were nonwhite (OR 1.79, 95% CI 0.94-3.40) or who had diabetes (OR 1.68, 95% CI 0.86-3.27) and among women with diabetes (OR 1.77, 95% CI 0.85-3.67), prior treatment of lower urinary tract symptoms (OR 2.58, 95% CI 1.22-5.46) or a higher depression level (OR 1.29, 95% CI 1.10-1.52). Baseline factors associated with more severe bother at 12 months in men included more severe bother at baseline, nonwhite race, worse urinary frequency and incontinence, and higher levels of stress (p <0.05). Among women more severe bother at baseline, urinary urgency and frequency, and worse physical function were associated with more severe bother at 12 months. CONCLUSIONS: Urinary symptom severity at baseline, race, depression and psychological stress were associated with the bother of lower urinary tract symptoms in a prospective cohort of men and women treated at tertiary care facilities. These findings may inform the clinical care of patients with bothersome lower urinary tract symptoms and direct providers to better prognosticate for patients with challenging lower urinary tract symptoms cases.
PURPOSE: Some patients continue to have bothersome lower urinary tract symptoms despite treatment. We examined characteristics associated with bother from lower urinary tract symptoms in a prospective cohort. MATERIALS AND METHODS: In this 1-year prospective, observational cohort study we obtained data on patients with lower urinary tract symptoms who were seeking care at a total of 6 tertiary care centers in the United States. Participants answered the AUA-SI (American Urological Association Symptom Index) global urinary bother question at study entry and 12 months later. Multilevel logistic and linear regression was used to identify factors associated with worsening bother and bother at 12 months, respectively. RESULTS: Of the 756 participants 121 (16%) had worsened lower urinary tract symptom bother during the study period. When adjusted for other variables, worsened lower urinary tract symptom bother was more likely among men who were nonwhite (OR 1.79, 95% CI 0.94-3.40) or who had diabetes (OR 1.68, 95% CI 0.86-3.27) and among women with diabetes (OR 1.77, 95% CI 0.85-3.67), prior treatment of lower urinary tract symptoms (OR 2.58, 95% CI 1.22-5.46) or a higher depression level (OR 1.29, 95% CI 1.10-1.52). Baseline factors associated with more severe bother at 12 months in men included more severe bother at baseline, nonwhite race, worse urinary frequency and incontinence, and higher levels of stress (p <0.05). Among women more severe bother at baseline, urinary urgency and frequency, and worse physical function were associated with more severe bother at 12 months. CONCLUSIONS: Urinary symptom severity at baseline, race, depression and psychological stress were associated with the bother of lower urinary tract symptoms in a prospective cohort of men and women treated at tertiary care facilities. These findings may inform the clinical care of patients with bothersome lower urinary tract symptoms and direct providers to better prognosticate for patients with challenging lower urinary tract symptoms cases.
Authors: David Cella; William Riley; Arthur Stone; Nan Rothrock; Bryce Reeve; Susan Yount; Dagmar Amtmann; Rita Bode; Daniel Buysse; Seung Choi; Karon Cook; Robert Devellis; Darren DeWalt; James F Fries; Richard Gershon; Elizabeth A Hahn; Jin-Shei Lai; Paul Pilkonis; Dennis Revicki; Matthias Rose; Kevin Weinfurt; Ron Hays Journal: J Clin Epidemiol Date: 2010-08-04 Impact factor: 6.437
Authors: Karin S Coyne; Alexandra I Barsdorf; Christine Thompson; Andrea Ireland; Ian Milsom; Chris Chapple; Zoe S Kopp; Tamara Bavendam Journal: Neurourol Urodyn Date: 2012-03-06 Impact factor: 2.696
Authors: Margaret E Helmuth; Abigail R Smith; Victor P Andreev; Gang Liu; H Henry Lai; Anne P Cameron; Nazema Y Siddiqui Journal: Am J Obstet Gynecol Date: 2017-12-26 Impact factor: 8.661
Authors: E David Crawford; Shandra S Wilson; John D McConnell; Kevin M Slawin; Michael C Lieber; Joseph A Smith; Alan G Meehan; Oliver M Bautista; William R Noble; John W Kusek; Leroy M Nyberg; Claus G Roehrborn Journal: J Urol Date: 2006-04 Impact factor: 7.450
Authors: L M Marshall; K F Holton; J K Parsons; J A Lapidus; K Ramsey; E Barrett-Connor Journal: Prostate Cancer Prostatic Dis Date: 2014-07-08 Impact factor: 5.554
Authors: Alexander P Glaser; Sarah Mansfield; Abigail R Smith; Brian T Helfand; H Henry Lai; Aruna Sarma; Claire C Yang; Michelle Taddeo; J Quentin Clemens; Anne P Cameron; Kathryn E Flynn; Victor Andreev; Matthew O Fraser; Bradley A Erickson; Ziya Kirkali; James W Griffith Journal: J Urol Date: 2022-02-25 Impact factor: 7.600
Authors: Whitney K Hendrickson; Cindy L Amundsen; David D Rahn; Isuzu Meyer; Megan S Bradley; Ariana L Smith; Deborah L Myers; J Eric Jelovsek; Emily S Lukacz Journal: Female Pelvic Med Reconstr Surg Date: 2021-03-01 Impact factor: 1.913
Authors: Kyle A Wegner; Hannah Ruetten; Nicholas M Girardi; Chelsea A O'Driscoll; Jaskiran K Sandhu; Anne E Turco; Lisa L Abler; Peiqing Wang; Zunyi Wang; Dale E Bjorling; Rita Malinowski; Richard E Peterson; Douglas W Strand; Paul C Marker; Chad M Vezina Journal: Am J Clin Exp Urol Date: 2021-02-15
Authors: Arthur L Burnett; David R Walker; Qi Feng; Karissa M Johnston; Greta Lozano-Ortega; David Nimke; John C Hairston Journal: Neurourol Urodyn Date: 2020-05-08 Impact factor: 2.696
Authors: Nnenaya Agochukwu-Mmonu; Jonathan B Wiseman; Abigail R Smith; Margaret E Helmuth; Aruna V Sarma; Anne P Cameron; Cindy L Amundsen; Kathryn E Flynn; David Cella; Kevin P Weinfurt; Ziya Kirkali; J Quentin Clemens Journal: Neurourol Urodyn Date: 2020-08-06 Impact factor: 2.696